Pubblicazioni

Human estrogen receptor Î± antagonists, part 2: Synthesis driven by rational design, in vitro antiproliferative, and in vivo anticancer evaluation of innovative coumarin-related antiestrogens as breast cancer suppressants

2022 - EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Kurtanovic, N.; Tomasevic, N.; Matic, S.; Mitrovic, M. M.; Kostic, D. A.; Sabatino, M.; Antonini, L.; Ragno, R.; Mladenovic, M.

Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies

2022 - EXPERT OPINION ON PHARMACOTHERAPY

Elia, G.; Ferrari, S. M.; Ragusa, F.; Paparo, S. R.; Mazzi, V.; Ulisse, S.; Benvenga, S.; Antonelli, A.; Fallahi, P.

Long-term response to immuno-oncology after discontinuation for immuno-related pneumonia in metastatic renal carcinoma: a case report

2022 - ANTI-CANCER DRUGS

Stellato, M.; Foderaro, S.; Tonini, G.; Vincenzi, B.; Santini, D.

The INCH trial - Induction chemotherapy in patients with bulky anal canal cancer: evaluation of the pilot phase

2021 - ANTICANCER RESEARCH

De Felice, F.; Fallarino, A.; Iafrate, F.; Maiuri, V.; Galloni, G.; Colonna, G. T.; De Pietro, R.; Chiarello, G.; Marchetti, C.; Bulzonetti, N.; Musio, D.; Tombolini, V.

Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: a systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

2021 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

De Felice, F.; Belgioia, L.; Alterio, D.; Bonomo, P.; Maddalo, M.; Paiar, F.; Denaro, N.; Corvo, R.; Merlotti, A.; Bossi, P.; Pappagallo, G. L.; D' Angelillo, R. M.; Magrini, S. M.; Arcangeli, S.

The importance of tumor stem cells in glioblastoma resistance to therapy

2021 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mattei, V.; Santilli, F.; Martellucci, S.; Monache, S. D.; Fabrizi, J.; Colapietro, A.; Angelucci, A.; Festuccia, C.

Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia

2021 - EXPERT OPINION ON DRUG SAFETY

Panzuto, F.; Magi, L.; Rinzivillo, M.

Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK

2021 - CELL REPORTS

Masi, I.; Caprara, V.; Spadaro, F.; Chellini, L.; Sestito, R.; Zancla, A.; Rainer, A.; Bagnato, A.; Rosano, L.

ImmuneOncology-tyrosine kinase inhibitors combination, sometimes less is more

2021 - INTERNATIONAL IMMUNOPHARMACOLOGY

Stellato, M.; Santini, D.

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of cliniciansâ attitudes

2020 - CLINICAL & TRANSLATIONAL ONCOLOGY.

Cortellini, A.; Leonetti, A.; Catino, A.; Pizzutillo, P.; Ricciuti, B.; De Giglio, A.; Chiari, R.; Bordi, P.; Santini, D.; Giusti, R.; De Tursi, M.; Brocco, D.; Zoratto, F.; Rastelli, F.; Citarella, F.; Russano, M.; Filetti, M.; Marchetti, P.; Berardi, R.; Torniai, M.; Cortinovis, D.; Sala, E.; Maggioni, C.; Follador, A.; Macerelli, M.; Nigro, O.; Tuzi, A.; Iacono, D.; Migliorino, M. R.; Banna, G.; Porzio, G.; Cannita, K.; Ferrara, M. G.; Bria, E.; Galetta, D.; Ficorella, C.; Tiseo, M.

Short-termÂ outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy used as treatment of colo-rectal carcinomatosis: a multicentric study

2020 - UPDATES IN SURGERY

Macri, A.; Arcoraci, V.; Belgrano, V.; Caldana, M.; Carbonari, L.; Cioppa, T.; De Cian, F.; De Manzoni, G.; De Simone, M.; Giardina, C.; Muffatti, F.; Orsenigo, E.; Robella, M.; Roviello, F.; Saladino, E.; Sammartino, P.; Vaira, M.

Aptamer-based in vivo therapeutic targeting of glioblastoma

2020 - MOLECULES

Cesarini, V.; Scopa, C.; Silvestris, D. A.; Scafidi, A.; Petrera, V.; Del Baldo, G.; Gallo, A.

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

2020 - THE ONCOLOGIST

Ali, S.; Moreau, A.; Melchiorri, D.; Camarero, J.; Josephson, F.; Olimpier, O.; Bergh, J.; Karres, D.; Tzogani, K.; Gisselbrecht, C.; Pignatti, F.

Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives

2020 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Barchiesi, G.; Mazzotta, M.; Krasniqi, E.; Pizzuti, L.; Marinelli, D.; Capomolla, E.; Sergi, D.; Amodio, A.; Natoli, C.; Gamucci, T.; Vizza, E.; Marchetti, P.; Botti, C.; Sanguineti, G.; Ciliberto, G.; Barba, M.; Vici, P.

Sunitinib in the treatment of thyroid cancer

2019 - CURRENT MEDICINAL CHEMISTRY

Ferrari, S. M.; Centanni, M.; Virili, C.; Miccoli, M.; Ferrari, P.; Ruffilli, I.; Ragusa, F.; Antonelli, A.; Fallahi, P.

Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences

2019 - JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Cirone, M.; Gilardini Montani, M. S.; Granato, M.; Garufi, A.; Faggioni, A.; D'Orazi, G.

Synthesis and characterisation of a new benzamide-containing nitrobenzoxadiazole as a GSTP1-1 inhibitor endowed with high stability to metabolic hydrolysis

2019 - JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

Di Paolo, V.; Fulci, C.; Rotili, D.; Sciarretta, F.; Lucidi, A.; Morozzo della Rocca, B.; De Luca, A.; Rosato, A.; Quintieri, L.; Caccuri, A. M.

Biological rationale for targeting MEK/ERK pathways in anti-cancer therapy and to potentiate tumour responses to radiation

2019 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Marampon, F.; Ciccarelli, C.; Zani, B. M.

Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas

2019 - DERMATOLOGIC THERAPY

Paolino, G.; Didona, D.; Scarno, M.; Tallarico, M.; Cantoresi, F.; Calvieri, S.; Mercuri, S. R.; Piccolo, D.; Bottoni, U.; Kyriakou, A.; Cantisani, C.

Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation

2019 - ONCOGENE

Mongiardi, M. P.; Radice, G.; Piras, M.; Stagni, V.; Pacioni, S.; Re, A.; Putti, S.; Ferre, F.; Farsetti, A.; Pallini, R.; Barila, D.; Levi, A.; Falchetti, M. L.

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment. A mono-institutional experience

2019 - RADIATION ONCOLOGY

Valeriani, M.; Marinelli, L.; MacRini, S.; Reverberi, C.; Aschelter, A. M.; De Sanctis, V.; Marchetti, P.; Tronnolone, L.; Osti, M. F.

Immunotherapy in HER2-positive breast cancer. state of the art and future perspectives

2019 - JOURNAL OF HEMATOLOGY & ONCOLOGY

Krasniqi, E.; Barchiesi, G.; Pizzuti, L.; Mazzotta, M.; Venuti, A.; Maugeri-Sacca, M.; Sanguineti, G.; Massimiani, G.; Sergi, D.; Carpano, S.; Marchetti, P.; Tomao, S.; Gamucci, T.; De Maria, R.; Tomao, F.; Natoli, C.; Tinari, N.; Ciliberto, G.; Barba, M.; Vici, P.

Relationship and predictive role of the dual expression of FGFR and IL-8 in metastatic renal cell carcinoma treated with targeted agents

2018 - ANTICANCER RESEARCH

Iacovelli, Roberto; De Tursi, Michele; Mosillo, Claudia; Ciardi, Antonio; Carella, Consiglia; Natoli, Clara; Naso, Giuseppe; Cortesi, Enrico

Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma

2018 - MEDICINE

Falcone, Rosa; Roberto, Michela; Filetti, Marco; Anselmi, Elisabetta; Marchetti, Paolo

Human biomolecular corona of Liposomal Doxorubicin: the overlooked factor in anticancer drug delivery

2018 - ACS APPLIED MATERIALS & INTERFACES

Caracciolo, Giulio; Palchetti, Sara; Digiacomo, Luca; Chiozzi, Riccardo Zene Zini; Capriotti, Anna Laura; Amenitsch, Heinz; Tentori, Paolo Maria; Palmieri, Valentina; Papi, Massimiliano; Cardarelli, Francesco; Pozzi, Daniela; LaganÃ , Aldo